Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
Ligand activation of fibroblast growth factor receptor-1 (FGFR-1) induces an angiogenic response following activation of multiple intracellular signaling substrates, including the Src family of nonreceptor tyrosine kinases (SFK). However, the direct association between FGFR-1 and SFK and the involvement of SFK in FGFR-1-dependent cell proliferation have been controversial. Structural variants ... of FGFR-1 are generated by alternative splicing which results in two major isoforms, containing either three (FGFR-1alpha) or two (FGFR-1beta) immunoglobulin-like domains in the extracellular region. To determine whether alternatively spliced FGFR-1 isoforms differentially activate SFK, we have examined FGF receptor-negative endothelial cells stably transfected with human cDNA encoding either FGFR-1alpha or FGFR-1beta. Transient activation of c-YES, the predominant SFK expressed in these endothelial cells, was restricted to FGFR-1beta transfectants following exposure to acidic fibroblast growth factor (FGF-1). Co-immunoprecipitation studies revealed that c-YES directly associated with FGFR-1beta. The Src homology (SH)2 domain (and not the SH3 domain) of c-YES was able to recognize tyrosine phosphorylated FGFR-1beta. FGFR-1beta-specific activation of c-YES was accompanied by its association with and activation of cortactin. FGF-1 treatment of both FGFR-1alpha and FGFR-1beta transfectants induced SFK-independent cellular proliferation and growth in low density cultures. At high density, under both anchorage-dependent and -independent conditions, FGF-1 failed to induce proliferation and growth of FGFR-1alpha transfectants. In contrast, FGF-1 induced proliferation, growth, and formation of cord-like structures in high density cultures of FGFR-1beta transfectants in an SFK-dependent manner. In vitro cord formation on Matrigel was restricted to FGFR-1beta transfectants in an SFK-dependent manner. Formation of vascular structures in vivo was limited to endothelial cells transfected with FGFR-1beta. Collectively, these results emphasize the roles of alternatively spliced FGFR-1 structural isoforms and activation of SFK as modulators of endothelial cell growth during the formation of neovascular structures.
Mesh Terms:
Alternative Splicing, Animals, Brain, Cell Proliferation, Cells, Cultured, Endothelial Cells, Fibroblast Growth Factor 1, Humans, Neovascularization, Physiologic, Protein Isoforms, Proto-Oncogene Proteins c-yes, Rats, Receptor, Fibroblast Growth Factor, Type 1, Signal Transduction, Transfection, src Homology Domains
Alternative Splicing, Animals, Brain, Cell Proliferation, Cells, Cultured, Endothelial Cells, Fibroblast Growth Factor 1, Humans, Neovascularization, Physiologic, Protein Isoforms, Proto-Oncogene Proteins c-yes, Rats, Receptor, Fibroblast Growth Factor, Type 1, Signal Transduction, Transfection, src Homology Domains
Arch. Biochem. Biophys.
Date: Jun. 01, 2006
PubMed ID: 16631103
View in: Pubmed Google Scholar
Download Curated Data For This Publication
198066
Switch View:
- Interactions 4